Phibro Animal Health (PAHC) Long-Term Investments (2019 - 2026)
Phibro Animal Health (PAHC) posted quarterly Long-Term Investments of $991000.0 for Q1 2026, down 84.54% year-over-year from $6.4 million in Q1 2025, and up 170.03% quarter-over-quarter from $367000.0 in Q4 2025.
Phibro Animal Health (PAHC) Long-Term Investments (2019 - 2026) Analysis & Trends
Phibro Animal Health's Long-Term Investments history runs 8 years deep, the most recent figure standing at $991000.0 for Q1 2026.
- In Q1 2026, Long-Term Investments fell 84.54% year-over-year to $991000.0; the TTM figure through Mar 2026 stood at $991000.0 (down 84.54% YoY), while the FY2025 annual figure was $5.1 million, down 18.45% from the prior year.
- Long-Term Investments for Q1 2026 stood at $991000.0, up from $367000.0 in the prior quarter.
- The five-year high for Long-Term Investments was $13.4 million in Q4 2022, with the low at $367000.0 in Q4 2025.
- The 5-year median for Long-Term Investments is $6.1 million (2023), against an average of $5.8 million.
- The sharpest annual moves came in 2022 and 2025: Long-Term Investments jumped 183.38% in 2022, then plunged 90.1% in 2025.
- Phibro Animal Health's Long-Term Investments stood at $13.4 million in 2022, then sank by 67.22% to $4.4 million in 2023, then dropped by 15.38% to $3.7 million in 2024, then plunged by 90.1% to $367000.0 in 2025, then jumped by 170.03% to $991000.0 in 2026.
- Business Quant data shows PAHC's Long-Term Investments at $991000.0 in Q1 2026, $367000.0 in Q4 2025, and $8.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 92.58 Mn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 63.23 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 1.14 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 149.10 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 60.00 Mn |
| 10 | Phibro Animal Health | 1.42 Bn | 1.35 Bn | 125.68 Mn | 8.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 991,000.00 |
| Dec 31, 2025 | 367,000.00 |
| Sep 30, 2025 | 8.35 Mn |
| Jun 30, 2025 | 5.14 Mn |
| Mar 31, 2025 | 6.41 Mn |
| Dec 31, 2024 | 3.71 Mn |
| Sep 30, 2024 | 6.40 Mn |
| Jun 30, 2024 | 6.31 Mn |
| Mar 31, 2024 | 6.17 Mn |
| Dec 31, 2023 | 4.38 Mn |
| Sep 30, 2023 | 6.10 Mn |
| Jun 30, 2023 | 10.23 Mn |
| Mar 31, 2023 | 6.09 Mn |
| Dec 31, 2022 | 13.37 Mn |
| Sep 30, 2022 | 6.01 Mn |
| Jun 30, 2022 | 4.36 Mn |
| Mar 31, 2022 | 4.06 Mn |
| Dec 31, 2021 | 4.72 Mn |
| Sep 30, 2021 | 4.76 Mn |
| Jun 30, 2021 | 4.14 Mn |